- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04893447
Suicide Prevention Among Recipients of Care (SPARC)
Comparing the Effectiveness of Safety Planning Plus Follow-Up From a Suicide Prevention Hotline (SPI+) vs Safety Planning Plus Caring Contacts (SP+CC) Among Adults and Adolescents at Risk for Suicide in Primary Care or Emergency Departments
Randomized controlled trial to determine the best brief suicide prevention intervention for adults and adolescents who screen positive for suicidal ideation or behavior in emergency departments or primary care clinics.
Aim 1: Compare the effectiveness of two brief suicide prevention interventions (safety planning intervention plus structured phone-based follow-up from a suicide prevention hotline (SPI+), versus safety planning intervention plus caring contacts (CC)) to (a) reduce suicidal ideation and behavior, (b) reduce loneliness, (c) reduce return to care for suicidality, and (d) increase uptake of outpatient mental healthcare services over 12 months among adult and adolescent patients screening positive for suicide in emergency departments (EDs) and primary care clinics.
Aim 2: Assess the acceptability of connection and support planning and the safety planning intervention, with or without follow-up among providers and clinical staff in EDs and primary care clinics.
Aim 3: Assess the acceptability of SPI+ and SP+CC among adult and adolescent patients.
Study Overview
Status
Conditions
- Adolescent
- Depressive Disorder
- Depression
- Suicidal Ideation
- Suicide, Attempted
- Suicide
- Mental Health
- Loneliness
- Social Support
- Mental Disorder
- Outpatients
- Ambulatory Care
- Continuity of Patient Care
- Adult
- Secondary Prevention
- Emergency Service, Hospital
- Mental Health Services
- Patient Care Planning
- Crisis Intervention
- Outpatient Clinics, Hospital
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna K Radin, DrPH, MPH
- Phone Number: 208-381-8468
- Email: Radina@slhs.org
Study Contact Backup
- Name: Jenny Shaw, MHS
- Phone Number: 208-388-7701
- Email: Shawje@slhs.org
Study Locations
-
-
Idaho
-
Boise, Idaho, United States, 83712
- St. Luke's Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient at St. Luke's Health System Emergency Department or Primary Care Clinic
- 12-17 years old (adolescents) or 18+ years old (adults)
- Screened positive for suicide risk on C-SSRS (any response of "yes") during current visit, or current visit is related to a suicide attempt
- Access to a phone for the duration of the study with the ability to receive calls
- The ability to send and receive email messages (required) and text messages (optional)
- English or Spanish speaking and reading
Exclusion Criteria:
- Unable or unwilling to provide informed consent to participate
- Inappropriate for study participation based on the clinical judgment of provider
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SPI+: Safety Planning Intervention plus structured phone-based follow-up
The Safety Planning Intervention (SPI+) includes safety planning (moderate or high risk for suicide) or connection & support planning (low risk for suicide) at the clinic or ED, plus a structured telephone-based intervention from a suicide prevention hotline
|
Suicide prevention hotline follow-up specialists will call participants to (1) conduct a brief suicide risk assessment; (2) review and discuss the participant's connection and support plan or safety plan; and (3) provide referrals to social services or other support with treatment engagement, if indicated.
Participants will receive at least one and optional additional phone calls, generally delivered according to the following schedule: days 3, 7, 14, 30, 60, 90.
Modifications may be made to the schedule due to weekends, holidays, or participant availability, and additional calls may be scheduled as desired by the participant.
The follow-up will stop once the participant is successfully engaged in outpatient treatment or does not desire further follow-up support.
Other Names:
|
Experimental: Caring Contacts: Safety Planning Intervention plus Caring Contacts (SP+CC)
SP+CC will include safety planning (moderate or high risk for suicide) or connection & support planning (low risk for suicide) at the clinic or ED, plus caring text messages or emails from a suicide prevention hotline.
|
SP+CC follow-up includes one phone conversation with a suicide prevention hotline follow-up specialist and a series of personalized caring messages sent over the course of 12 months via text or email (based on participant preference).
Caring contacts will generally be sent according to the following schedule: 3 in the first week, 6 weekly, 6 bi-weekly, 4 monthly; 2 bi-monthly, and one each for the participant's birthday, Thanksgiving, Christmas, and New Year's (total of 25 over 12 months).
Slight variation in the schedule is allowed.
There is no expectation that participants respond to the text messages; if they do, follow-up specialists reply to any incoming texts.
Replies are individually-tailored and caring.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Suicidal Ideation & Behavior; measured using the Columbia Suicide Severity Rating Scale (C-SSRS) since-last-contact screener (self-assessment)
Time Frame: 6 months
|
6-item questionnaire with yes/no response options.
Scores range from 0 (no risk) to 6 (high risk)
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Loneliness; measured using the NIH Toolbox Emotion Batteries Loneliness Scale
Time Frame: 6 months
|
5-item questionnaire with Likert scale response options (1=never, 5=always).
Scores range from 5 (no loneliness) to 25 (high levels of loneliness).
|
6 months
|
Loneliness; measured using the NIH Toolbox Emotion Batteries Loneliness Scale
Time Frame: 12 months
|
5-item questionnaire with Likert scale response options (1=never, 5=always).
Scores range from 5 (no loneliness) to 25 (high levels of loneliness).
|
12 months
|
Utilization of Emergency Department for Suicidality
Time Frame: 6 months
|
Measured through self-report
|
6 months
|
Utilization of Emergency Department for Suicidality
Time Frame: 12 months
|
Measured through self-report
|
12 months
|
Attendance at Outpatient Behavioral Health Appointments
Time Frame: 6 months
|
Measured through self-report
|
6 months
|
Attendance at Outpatient Behavioral Health Appointments
Time Frame: 12 months
|
Measured through self-report
|
12 months
|
Suicidal Ideation & Behavior; measured using the Columbia Suicide Severity Rating Scale (C-SSRS) since-last-contact screener (self-assessment)
Time Frame: 12 months
|
6-item questionnaire with yes/no response options.
Scores range from 0 (no risk) to 6 (high risk)
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Anna K Radin, DrPH, MPH, St. Luke's Health System
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-0026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent
-
University of CoimbraRecruitingAdolescent Behavior | Adolescent - Emotional ProblemPortugal
-
National Institute of Environmental Health Sciences...RecruitingAdolescent Health | Pediatrics | Adolescent Development | Reproductive Physiological ProcessesUnited States
-
University of MinnesotaNational Institute on Minority Health and Health Disparities (NIMHD); SoLaHmoCompletedAdolescent Health | Adolescent School Connectedness | Community Based Participatory Research MethodsUnited States
-
Friends Research Institute, Inc.Conrad N. Hilton FoundationCompletedAdolescent Behavior | Adolescent Health ServicesUnited States
-
World Health OrganizationLondon School of Hygiene and Tropical Medicine; University of Ghana; Biomedical... and other collaboratorsRecruitingHealth-Related Behavior | Adolescent Behavior | Adolescent Development | Health Care Seeking BehaviorGhana, Tanzania, Zimbabwe
-
Aksaray UniversityEskisehir Osmangazi UniversityRecruiting
-
Eastern Mediterranean UniversityRecruiting
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
University of KlagenfurtCardiff University; Medical University of Vienna; Bielefeld University; Institute... and other collaboratorsRecruitingParent-Child Relations | Parenting | Adolescent Behavior | Adolescent - Emotional Problem | Psychological Well-BeingMoldova, Republic of, North Macedonia
-
Eunice Kennedy Shriver National Institute of Child...Completed
Clinical Trials on SPI+
-
University of Firenze and Siena, Napoli, ItalyCompletedThick Gingival Margin to Tooth RestorationItaly
-
Aisthesis Medical P.C.Larissa University Hospital; Technical University of CreteRecruitingInfections | Sepsis | Hemodynamic Instability | Abdominal Sepsis | Clinical DeteriorationGreece
-
Spectrum Pharmaceuticals, IncCompleted
-
Sparrow PharmaceuticalsRecruitingAutonomous Cortisol Secretion (ACS) | ACTH-Independent Cushing Syndrome | ACTH-Independent Adrenal Cushing Syndrome, SomaticUnited States, United Kingdom, France, Romania
-
Alpha - Bio Tec Ltd.CompletedImplant Clinical Survival | Dental Implant Bone LossChina
-
San Diego State UniversityNational Institute of Mental Health (NIMH)RecruitingSuicideUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)Enrolling by invitationSuicidal Ideation | SuicideUnited States
-
Università degli Studi di FerraraUniversity Health Network, Toronto; Princess Margaret Hospital, CanadaUnknownDepression | Quality of Life | AnxietyItaly
-
Michigan State UniversityBrown UniversityUnknownSuicideUnited States
-
Sun Yat-sen UniversityWest China Hospital; Chongqing Medical University; The Second Affiliated Hospital... and other collaboratorsRecruitingPrimary Angle Closure GlaucomaChina